SEC Form 4 · accession 0001209191-16-116801
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
W Thorpe McKenzie
Director · 10% Owner
Period of report
Mar 1, 2016
Accepted (ET)
May 2, 2016 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $7.79 | Mar 1, 2016 | M | 15,000 | A | Mar 1, 2016 | Feb 28, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1On March 1, 2016 (the Grant Date) W. Thorpe McKenzie was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purcahse shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The options vested immediately upon grant with an expiry of ten years from the Grant Date.
Remarks
Exhibit 24 - Power of Attorney